
|Articles|May 7, 2015
Surgical Treatment of Benign Prostatic Hyperplasia (sponsored)
On January 10, 2015 Urology Times convened an expert panel to examine the criteria that constitute a gold standard for the treatment of male lower urinary tract symptoms (LUTS), or benign prostatic hyperplasia (BPH).
Advertisement
Surgical Treatment of Benign Prostatic Hyperplasia
What Defines a Gold Standard?
On January 10, 2015 Urology Times convened an expert panel to examine the criteria that constitute a gold standard for the treatment of male lower urinary tract symptoms (LUTS), or benign prostatic hyperplasia (BPH).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











